AG

Artal Group Portfolio holdings

AUM $930M
1-Year Return 3.57%
This Quarter Return
+49.95%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$2.93B
AUM Growth
+$639M
Cap. Flow
-$173M
Cap. Flow %
-5.9%
Top 10 Hldgs %
77.18%
Holding
114
New
14
Increased
16
Reduced
25
Closed
23

Top Buys

1
ARGX icon
argenx
ARGX
$44.3M
2
SRRK icon
Scholar Rock
SRRK
$41.4M
3
ARWR icon
Arrowhead Research
ARWR
$31.3M
4
KRRO icon
Korro Bio
KRRO
$20.1M
5
KYMR icon
Kymera Therapeutics
KYMR
$18.5M

Top Sells

1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
$88.2M
2
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$69.4M
3
FOLD icon
Amicus Therapeutics
FOLD
$28.9M
4
CYTK icon
Cytokinetics
CYTK
$25.4M
5
IMGN
Immunogen Inc
IMGN
$24M

Sector Composition

1 Healthcare 51.64%
2 Consumer Discretionary 47.64%
3 Technology 0.45%
4 Real Estate 0.14%
5 Communication Services 0.09%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
NBTX
101
Nanobiotix
NBTX
$411M
– –
-1,000,000
Closed -$8.75M
NFLX icon
102
Netflix
NFLX
$534B
– –
-1,285
Closed -$485K
NTLA icon
103
Intellia Therapeutics
NTLA
$1.25B
– –
-276,077
Closed -$8.73M
PLRX icon
104
Pliant Therapeutics
PLRX
$100M
– –
-1,490
Closed -$26K
RNA icon
105
Avidity Biosciences
RNA
$6.24B
– –
-300,000
Closed -$1.91M
VERV
106
DELISTED
Verve Therapeutics
VERV
– –
-300,000
Closed -$3.98M
VRDN icon
107
Viridian Therapeutics
VRDN
$1.52B
– –
-504,978
Closed -$7.75M
VTYX icon
108
Ventyx Biosciences
VTYX
$185M
– –
-405,239
Closed -$14.1M
XYZ
109
Block, Inc.
XYZ
$46.2B
– –
-15,500
Closed -$686K
KA
110
DELISTED
Kineta, Inc. Common Stock
KA
– –
-31,055
Closed -$106K
RYZB
111
DELISTED
RayzeBio, Inc. Common Stock
RYZB
– –
-555,556
Closed -$12.3M
IMGN
112
DELISTED
Immunogen Inc
IMGN
– –
-1,512,113
Closed -$24M
MRTX
113
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-2,024,226
Closed -$88.2M
SQZ
114
DELISTED
SQZ Biotechnologies Company
SQZ
– –
-1,606,309
Closed -$129K
1 2 3 4
5